نتایج جستجو برای: 131 therapy

تعداد نتایج: 668160  

2011
Raef Riad Magdy Kotb Walid Omar Ahmed Zaher Emad Ebied Alexander Gregory Pitman Hussein Abdel Dayem

Radio-labelled MIBG therapy has been tried in the treatment of advanced stage III and IV neuroblastoma in an attempt to improve patients outcome. The use of radiolabelled MIBG to treat neuroblastoma has arisen from the high sensitivity and specificity of in vivo MIBG imaging for detection of primary and metastatic tumours. Although, clinical trials have been performed to determine the role of M...

2012
Hojjat Ahmadzadehfar Amir Sabet Hans Jürgen Biersack Jörn Risse

Therapy in nuclear medicine practice has a long distinguished history. Nuclear medicine therapy is required to be highly specific and targeted, since it always involves administration of unsealed sources of radioactivity. Most therapy agents utilize ß-particle emissions for their ability to penetrate tissues. This deposition of energy in tissue by ß emitters results in cellular damage. Among th...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004
Steven G DuBois Julia Messina John M Maris John Huberty David V Glidden Janet Veatch Martin Charron Randall Hawkins Katherine K Matthay

PURPOSE Iodine-131-metaiodobenzylguanidine ((131)I-MIBG) has been shown to be active against refractory neuroblastoma. The primary toxicity of (131)I-MIBG is myelosuppression, which might necessitate autologous hematopoietic stem-cell transplantation (AHSCT). The goal of this study was to determine risk factors for myelosuppression and the need for AHSCT after (131)I-MIBG treatment. PATIENTS ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Thomas A Davis Mark S Kaminski John P Leonard Frank J Hsu Mary Wilkinson Andrew Zelenetz Richard L Wahl Stewart Kroll Morton Coleman Michael Goris Ronald Levy Susan J Knox

PURPOSE A multicenter, randomized study was undertaken to estimate the single agent activity of Tositumomab and to determine the contribution of radioisotope-labeling with (131)I to activity and toxicity by comparing treatment outcomes for Tositumomab and Iodine I 131 Tositumomab (BEXXAR) to an equivalent total dose of unlabeled Tositumomab. EXPERIMENTAL DESIGN Seventy-eight patients with ref...

Journal: :International Journal of Radiation Oncology*Biology*Physics 2016

2015
Camille Esquerré-Lamare François Isus Nathalie Moinard Louis Bujan

BACKGROUND Treatment of differentiated thyroid cancer usually consists of a total thyroidectomy followed by one or several courses of radioiodine ((131)I). (131)I is known to have deleterious effects on radiation sensitive tissues and irradiation to the testes has been shown after its administration. We investigated effects of such treatment on sperm DNA in a patient with differentiated thyroid...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید